查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1586173

細胞分析市場：按產品、流程和最終用戶分類 - 全球預測 2025-2030

Cell Analysis Market by Product (Cell Counters, Cell Microarrays, Flow Cytometry Products), Process (Cell Counting & Quality Control, Cell Identification, Cell Interaction), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年細胞分析市值為221.4億美元，預計2024年將達到242.5億美元，複合年成長率為9.58%，到2030年將達到420.3億美元。

細胞分析是生命科學中的關鍵過程，也是研究、診斷和治療開發的基石。它涉及檢查細胞以深入了解它們的功能、特性和相互作用。細胞分析的需求源自於疾病理解、藥物開發和個人化醫療進步的應用。其應用範圍廣泛，包括藥物發現、癌症研究和幹細胞研究，最終用途主要是醫療機構、研究機構和生物技術公司。市場成長的主要驅動力是高通量篩檢和單細胞分析技術等技術進步、慢性病盛行率上升以及政府支持細胞研究的措施。開發自動化和人工智慧驅動的細胞分析儀器的機會比比皆是，這有望提高效率和準確性。此外，新型再生醫學和免疫治療研究中擴大採用細胞分析，預計將顯著成長。然而，先進細胞分析系統的高成本、樣品製備的複雜性以及某些細胞療法的倫理問題等挑戰可能會阻礙市場擴張。另一個阻礙因素是這些技術產生的大量資料的資料管理問題。應對這些挑戰需要技術創新，重點是開發具有成本效益的解決方案、簡化流程和增強資料分析能力。最有前景的創新領域包括整合機器學習演算法以改進預測分析以及分析工具的小型化以促進實驗室晶片解決方案。這些創新可以大大提高各種最終使用環境中的擴充性和可訪問性。市場充滿活力且競爭激烈，企業有機會透過產品差異化和附加價值服務來實現差異化。隨著競爭格局的不斷發展，透過採取跨學科方法和促進合作來保持領先地位對於維持成長和在市場格局中保持競爭力至關重要。

主要市場統計
基準年[2023] 221.4億美元
預測年份 [2024] 242.5億美元
預測年份 [2030] 420.3億美元
複合年成長率（%） 9.58%

市場動態：揭示快速發展的細胞分析市場的關鍵市場洞察

細胞分析市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 慢性病及感染疾病率增加
    • 介紹技術先進的產品和診斷實驗室
    • 政府對生命科學的投資以及生物製藥和生物技術產業的快速擴張
  • 市場限制因素
    • 缺乏熟練的專業人員
  • 市場機會
    • 研究開發和新產品開發的合作活動
    • 細胞分析在個人化醫療的應用
  • 市場挑戰
    • 複雜且耗時的監管指南

波特的五力：駕馭細胞分析市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解細胞分析市場的外部影響

外部宏觀環境因素在塑造細胞分析市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解細胞分析市場的競爭狀況

細胞分析市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣細胞分析市場供應商績效評估

FPNV定位矩陣是評估細胞分析市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了細胞分析市場的成功之路

細胞分析市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病和感染疾病的發生率增加
      • 介紹技術先進的產品和診斷實驗室
      • 政府對生命科學的投資以及生物製藥和生物技術產業的快速擴張
    • 抑制因素
      • 缺乏熟練的專業人員
    • 機會
      • 研究開發和新產品開發的合作活動
      • 細胞分析在個人化醫療的應用
    • 任務
      • 複雜且耗時的監管指南
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章細胞分析市場：依產品

  • 細胞計數器
  • 細胞微陣列
  • 流式細胞技術產品
  • 高內涵篩檢系統
  • 顯微鏡
  • 定量PCR產品
  • 光強度

第7章細胞分析市場：依流程

  • 細胞計數和品管
  • 細胞識別
  • 細胞交互作用
  • 細胞增殖
  • 細胞訊號傳導途徑或訊號傳導
  • 細胞結構研究
  • 細胞活力
  • 單細胞分析
  • 目標識別與檢驗

第 8 章 細胞分析市場：依最終使用者分類

  • 細胞培養物保藏庫
  • 合約調查機構
  • 醫院和診斷實驗室
  • 製藥和生物技術公司
  • 調查機構

第9章北美和南美細胞分析市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太細胞分析市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲細胞分析市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Agilent Technologies Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • BioStatus Limited
  • Carl Zeiss AG
  • Cell Biolabs, Inc.
  • Creative Bioarray
  • Cytek Biosciences
  • Danaher Corporation
  • EVIDENT
  • GE Healthcare
  • Meiji Techno
  • Merck KGaA
  • Miltenyi Biotec BV & Co. KG
  • Nanocellect Biomedical
  • PerkinElmer Inc.
  • Promega Corporation
  • Sysmex America, Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific
Product Code: MRR-431F213C90BB

The Cell Analysis Market was valued at USD 22.14 billion in 2023, expected to reach USD 24.25 billion in 2024, and is projected to grow at a CAGR of 9.58%, to USD 42.03 billion by 2030.

Cell analysis is a critical process in life sciences, serving as a cornerstone in research, diagnostics, and therapeutic developments. It involves examining cells for insights into their functions, characteristics, and interactions. The necessity of cell analysis stems from its applications in understanding diseases, developing drugs, and advancing personalized medicine. Its applications are broad, including drug discovery, cancer research, and stem cell research, with end-use predominant in healthcare institutions, research organizations, and biotechnology firms. Market growth is primarily driven by technological advancements such as high-throughput screening and single-cell analysis technologies, rising prevalence of chronic disorders, and government initiatives supporting cell-based research. Opportunities abound in the development of automated and AI-driven cell analysis instruments, which promise increased efficiency and precision. Moreover, expanding adoption of cell analysis in novel regenerative medicine and immunotherapy research presents significant growth prospects. However, challenges such as high costs of advanced cell analysis systems, complexities in sample preparation, and ethical concerns regarding certain cell therapies may hinder market expansion. Limitations also include data management issues due to the vast amount of data generated by these technologies. To combat these challenges, emphasis on innovation could focus on developing cost-effective solutions, simplifying processes, and enhancing data analytics capabilities. The most promising areas for innovation include integrating machine learning algorithms to improve predictive analytics and the miniaturization of analysis tools to promote lab-on-a-chip solutions. These innovations can significantly enhance scalability and accessibility in various end-use environments. The market is dynamic and highly competitive, with opportunities for companies to differentiate themselves through product differentiation and value-added services. As the landscape continues to evolve, staying ahead by embracing cross-disciplinary approaches and fostering collaborations will be essential for sustaining growth and maintaining a competitive edge in the cell analysis market.

KEY MARKET STATISTICS
Base Year [2023] USD 22.14 billion
Estimated Year [2024] USD 24.25 billion
Forecast Year [2030] USD 42.03 billion
CAGR (%) 9.58%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell Analysis Market

The Cell Analysis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidence of chronic and infectious diseases
    • Introduction of technologically advanced products and diagnostic laboratories
    • Government investments in life sciences sector and rapid expansion of the biopharmaceutical & biotechnological industry
  • Market Restraints
    • Limited availability of skilled professionals
  • Market Opportunities
    • Collaboration activities for R&D and new product development
    • Applications of cell analysis in personalized medicine
  • Market Challenges
    • Complex & time-consuming regulatory guidelines

Porter's Five Forces: A Strategic Tool for Navigating the Cell Analysis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell Analysis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell Analysis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell Analysis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell Analysis Market

A detailed market share analysis in the Cell Analysis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell Analysis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell Analysis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell Analysis Market

A strategic analysis of the Cell Analysis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Analysis Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., BioStatus Limited, Carl Zeiss AG, Cell Biolabs, Inc., Creative Bioarray, Cytek Biosciences, Danaher Corporation, EVIDENT, GE Healthcare, Meiji Techno, Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Nanocellect Biomedical, PerkinElmer Inc., Promega Corporation, Sysmex America, Inc., Tecan Trading AG, and Thermo Fisher Scientific.

Market Segmentation & Coverage

This research report categorizes the Cell Analysis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Cell Counters, Cell Microarrays, Flow Cytometry Products, High-Content Screening Systems, Microscopes, QPCR Products, and Spectrophotometers.
  • Based on Process, market is studied across Cell Counting & Quality Control, Cell Identification, Cell Interaction, Cell Proliferation, Cell Signaling Pathway or Signal Transduction, Cell Structure Study, Cell Viability, Single-Cell Analysis, and Target Identification & Validation.
  • Based on End-User, market is studied across Cell Culture Collection Repositories, Contract Research Organizations, Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of chronic and infectious diseases
      • 5.1.1.2. Introduction of technologically advanced products and diagnostic laboratories
      • 5.1.1.3. Government investments in life sciences sector and rapid expansion of the biopharmaceutical & biotechnological industry
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Collaboration activities for R&D and new product development
      • 5.1.3.2. Applications of cell analysis in personalized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Complex & time-consuming regulatory guidelines
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cell Analysis Market, by Product

  • 6.1. Introduction
  • 6.2. Cell Counters
  • 6.3. Cell Microarrays
  • 6.4. Flow Cytometry Products
  • 6.5. High-Content Screening Systems
  • 6.6. Microscopes
  • 6.7. QPCR Products
  • 6.8. Spectrophotometers

7. Cell Analysis Market, by Process

  • 7.1. Introduction
  • 7.2. Cell Counting & Quality Control
  • 7.3. Cell Identification
  • 7.4. Cell Interaction
  • 7.5. Cell Proliferation
  • 7.6. Cell Signaling Pathway or Signal Transduction
  • 7.7. Cell Structure Study
  • 7.8. Cell Viability
  • 7.9. Single-Cell Analysis
  • 7.10. Target Identification & Validation

8. Cell Analysis Market, by End-User

  • 8.1. Introduction
  • 8.2. Cell Culture Collection Repositories
  • 8.3. Contract Research Organizations
  • 8.4. Hospitals & Diagnostic Laboratories
  • 8.5. Pharmaceutical & Biotechnology Companies
  • 8.6. Research Institutes

9. Americas Cell Analysis Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cell Analysis Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cell Analysis Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies Inc.
  • 2. Becton, Dickinson and Company
  • 3. Bio-Rad Laboratories Inc.
  • 4. BioStatus Limited
  • 5. Carl Zeiss AG
  • 6. Cell Biolabs, Inc.
  • 7. Creative Bioarray
  • 8. Cytek Biosciences
  • 9. Danaher Corporation
  • 10. EVIDENT
  • 11. GE Healthcare
  • 12. Meiji Techno
  • 13. Merck KGaA
  • 14. Miltenyi Biotec B.V. & Co. KG
  • 15. Nanocellect Biomedical
  • 16. PerkinElmer Inc.
  • 17. Promega Corporation
  • 18. Sysmex America, Inc.
  • 19. Tecan Trading AG
  • 20. Thermo Fisher Scientific

LIST OF FIGURES

  • FIGURE 1. CELL ANALYSIS MARKET RESEARCH PROCESS
  • FIGURE 2. CELL ANALYSIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CELL ANALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CELL ANALYSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CELL ANALYSIS MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CELL ANALYSIS MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CELL ANALYSIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CELL ANALYSIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CELL ANALYSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CELL ANALYSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CELL ANALYSIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CELL ANALYSIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CELL ANALYSIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CELL ANALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CELL ANALYSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CELL ANALYSIS MARKET DYNAMICS
  • TABLE 7. GLOBAL CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL COUNTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CELL ANALYSIS MARKET SIZE, BY FLOW CYTOMETRY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELL ANALYSIS MARKET SIZE, BY HIGH-CONTENT SCREENING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CELL ANALYSIS MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELL ANALYSIS MARKET SIZE, BY QPCR PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CELL ANALYSIS MARKET SIZE, BY SPECTROPHOTOMETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL COUNTING & QUALITY CONTROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL INTERACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL PROLIFERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL SIGNALING PATHWAY OR SIGNAL TRANSDUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL STRUCTURE STUDY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL VIABILITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CELL ANALYSIS MARKET SIZE, BY SINGLE-CELL ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CELL ANALYSIS MARKET SIZE, BY TARGET IDENTIFICATION & VALIDATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL CULTURE COLLECTION REPOSITORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CELL ANALYSIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CELL ANALYSIS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CELL ANALYSIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CELL ANALYSIS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES CELL ANALYSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. PHILIPPINES CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. SINGAPORE CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. SINGAPORE CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. SOUTH KOREA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. SOUTH KOREA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 81. SOUTH KOREA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. TAIWAN CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. TAIWAN CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 84. TAIWAN CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. THAILAND CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. THAILAND CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 87. THAILAND CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. VIETNAM CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. VIETNAM CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 90. VIETNAM CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 95. DENMARK CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. DENMARK CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 97. DENMARK CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. EGYPT CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. EGYPT CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 100. EGYPT CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. FINLAND CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. FINLAND CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 103. FINLAND CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. FRANCE CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. FRANCE CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 106. FRANCE CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. GERMANY CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. GERMANY CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 109. GERMANY CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. ISRAEL CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. ISRAEL CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 112. ISRAEL CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. ITALY CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. ITALY CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 115. ITALY CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. NETHERLANDS CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. NETHERLANDS CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 118. NETHERLANDS CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. NIGERIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. NIGERIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 121. NIGERIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. NORWAY CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. NORWAY CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 124. NORWAY CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. POLAND CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. POLAND CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 127. POLAND CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. QATAR CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. QATAR CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 130. QATAR CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. RUSSIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. RUSSIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 133. RUSSIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SAUDI ARABIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SAUDI ARABIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 136. SAUDI ARABIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. SOUTH AFRICA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. SOUTH AFRICA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 139. SOUTH AFRICA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. SPAIN CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. SPAIN CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 142. SPAIN CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. SWEDEN CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. SWEDEN CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 145. SWEDEN CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. SWITZERLAND CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. SWITZERLAND CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 148. SWITZERLAND CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. TURKEY CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. TURKEY CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 151. TURKEY CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED ARAB EMIRATES CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. UNITED ARAB EMIRATES CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 154. UNITED ARAB EMIRATES CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. UNITED KINGDOM CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. UNITED KINGDOM CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 157. UNITED KINGDOM CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. CELL ANALYSIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 159. CELL ANALYSIS MARKET, FPNV POSITIONING MATRIX, 2023